In this pilot, cross-sectional study, we explored the possible clinical significance of measuring urinary levels of the post-translational modified form of human fetuin-A (PTM-FetA) in a mixed cohort of patients with non-advanced CKD of various etiology. The gene discussed is AHSG; the disease is chronic kidney disease.